Inhibitors of sterol metabolism for their use to accumulate triglycerides in microalgae, and methods thereof

US2016348138A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016348138-A1
Application numberUS-201515112886-A
CountryUS
Kind codeA1
Filing dateJan 27, 2015
Priority dateJan 27, 2014
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method for accumulating triacylglycerols in microalgae by inhibiting the sterol metabolism, N by incubating the microalgae with an inhibitor of sterol metabolism. The invention also relates to a method for producing fatty acids, biofuels, pharmaceutical or cosmetic compositions, and also food supplements, comprising a triacylglycerols accumulation step in microalgae according to the invention. Finally, the invention concerns the use of an inhibitor of sterol metabolism to accumulate triglycerides in microorganisms, and preferably microalgae.

First claim

Opening claim text (preview).

1 . A method for triggering triacylglycerols accumulation in microalgae by inhibiting the sterol metabolism, by incubating the microalgae with an inhibitor of sterol metabolism. 2 . A method according to claim 1 , wherein the incubation step is implemented in a nitrogen medium. 3 . A method according to claim 1 , wherein the microalgae is selected from the group consisting of microalgae of the diatom phylum, the Chromalveolata phylum, and the Archaeplastidae phylum. 4 . A method according to claim 3 , wherein the microalgae is selected from the diatom micro-algae species Phaeodactylum tricomutum and Thalassiosira pseudonana , the Chromalveolata micro-algae species Nannochloropsis , and the Archaeplastidae micro-algae species Chlamydomonas, Ostreococcus , and Chlorella. 5 . A method according to claim 1 , wherein the inhibitor of sterol metabolism is a compound of formula (I) or a salt thereof: wherein: R 41 and R 42 , identical or different, represent a hydrogen atom, alkyl, alkenyl, alkynyl, or hydroxyl, —COR 4a or —COOR 4a group, in which R 4a represents a hydrogen atom, a linear or branched alkyl, aryl, heteroaryl group, optionally substituted with one or more groups independently selected from alkyl or cycloalkyl groups, or R 41 and R 42 form together an oxygen atom attached by a double bond; R 43 represents a hydrogen atom, or an alkyl group; and R 44 , R 45 and R 46 , identical or different, represent a hydrogen atom, an alkyl, alkoxy, hydroxyl group, or an oxygen atom attached by a double bond, said alkyl group being optionally substituted with one or more halogen atoms, and including optionally in its chain one or more sulfoxide functions. 6 . A method according to claim 1 , wherein the inhibitor of sterol metabolism is a compound of formula (II): wherein; W 3 , X 3 , Y 3 and Z 3 represent carbon, sulphur, nitrogen or oxygen atom; n 3 and n 3′ , independently, are integer equal to 0 or 1 R 31 and R 32 , identical or different, represent a hydrogen atom, linear or branched alkyl, alkenyl, alkynyl, alkylalkenyl, alkynylalkenyl, cycloalkyl, alkylaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroalkyl, heteroaryl groups, or form together a cycloalkyl group comprising 5 to 6 carbon atoms, one or two carbon atoms of said cycloalkyl group being optionally replaced by one or two heteroatoms, or one of R 31 or R 32 form together with R 39 a cycloalkyl group comprising 5 to 6 carbon atoms, one or two carbon atoms of said cycloalkyl group being possibly replaced by one or two heteroatoms, said R 31 or R 32 being optionally substituted with one or more groups independently selected from linear or branched alkyl, cycloalkyl), alkynyl, arylalkyl, aryl, heteroaryl, hydroxyl, halogen, nitro, —COR 3a or —NR 3a R 3b group, in which R 3a and R 3b , identical or different, represent a hydrogen atom, or a linear or branched alkyl chain; R 33 represents a hydrogen atom, a linear or branched alkyl chain, or a nitrile group; R 34 , R 35 , R 36 , R 37 , R 38 and R 39 , identical or different, represent hydrogen or halogen atoms, or hydroxyl groups. 7 . A method according to claim 1 , wherein the inhibitor of sterol metabolism is a compound of formula (III): wherein: n 1 ranges from 1 to 12, R 11 represents a hydrogen atom; a —COR 1a group, in which R 1a is a group selected from a linear or branched alkyl chain, optionally substituted with one or more groups independently selected from hydroxyl, halogen, nitro, optionally substituted benzyl groups, or optionally substituted aryl groups such as phenyl groups, said aryl groups being eventually substituted with one or more groups independently selected from halogen atoms and methyl groups; R 12 , R 13 and R 14 , identical or different, represent a hydrogen atom; a linear or branched alkyl chain; a hydroxyl group; a —CH 2 OH group; a —COOR 1b group, in which R 1b represents a hydrogen atom, or a linear or branched alkyl chain; a —OsiR 1c R 1d R 1e group, in which R 1c , R 1d and R 1e , identical or different, represent a hydrogen atom, or a linear or branched alkyl chain; or R 12 and R 13 form together an exo methylene group; R 15 represents a hydroxyl; a —OSiR 1c R 1d R 1e group; a —COOR 1f group, in which R 1f represents a hydrogen atom, or a linear or branched alkyl chain; a —OCOR 1g group, in which R 1g represents a linear or branched alkyl chain; or R 15 is a carbon forming an ethylenic unsaturation with the tetrahydropyranone ring, 8 . A method according to claim 1 , wherein the inhibitor of sterol metabolism is selected from the group consisting of Ethinylestradiol, Estrone, Butenafine, Mevastatin, Simvastatin, and Terbinafine. 9 . A method for producing fatty acids comprising a triggering of triacylglycerols accumulation step in microalgae as defined according to claim 1 . 10 . A method for producing biofuels comprising the following steps; (i) a triggering of triacylglycerols accumulation step in microalgae as defined according to claim 1 , followed by (ii) an extraction step of the triacylglycerols accumulated in microalgae during step (i), and (iii) a trans-esterification step of the triacylglycerols recovered during step (ii). 11 . A method for producing pharmaceutical or cosmetic compositions comprising the following steps: (i′) a triggering of triacylglycerols accumulation step in microalgae as defined according to claim 1 , followed by (ii′) an extraction step of the triacylglycerols accumulated in microalgae during step (i′), and (iii′) a step of adding at least one pharmaceutically or cosmetically acceptable excipient to the triacylglycerols recovered during step (ii′). 12 . A method for producing food supplements comprising the following steps: (I″) a triggering of triacylglycerols accumulation step in microalgae as defined according to claim 1 , followed by (ii″) an extraction step of the triacylglycerols accumulated in microalgae during step (i″), and (iii″) a step of adding at least one food additive to the triacylglycerols recovered during step (ii″). 13 . The use of an inhibitor of sterol metabolism to accumulate triglycerides in microorganism. 14 . The use according to claim 13 , wherein the inhibitor of sterol metabolism is chosen from the compounds of formula (I), (II) and (III), as defined in claim 6 . 15 . The use according to claim 14 , wherein the inhibitor of sterol metabolism is selected from the group consisting of Ethinylestradiol, Estrone, Butenafine, Mevastatin, Simvastatin, Terbinafine, and combinations thereof. 16 . A method according to claim 3 , wherein the microalgae is selected from the group consisting of Nannochloropsis gaditana, Nannochloropsis oceanica , and Nannochloropsis salina. 17 . A method according to claim 6 , wherein in the compound of formula (II): n 3 and n 3′ are equal to 1.

Assignees

Inventors

Classifications

  • Composting, fermenting or anaerobic digestion fuel components or materials from which fuels are prepared · CPC title

  • C12P7/6463Primary

    obtained from glyceride producing microorganisms, e.g. single cell oil · CPC title

  • Renewables or materials of biological origin · CPC title

  • essentially based on components consisting of carbon, hydrogen, and oxygen only · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016348138A1 cover?
The invention relates to a method for accumulating triacylglycerols in microalgae by inhibiting the sterol metabolism, N by incubating the microalgae with an inhibitor of sterol metabolism. The invention also relates to a method for producing fatty acids, biofuels, pharmaceutical or cosmetic compositions, and also food supplements, comprising a triacylglycerols accumulation step in microalgae a…
Who is the assignee on this patent?
Commissariat Energie Atomique, Centre Nat Rech Scient
What technology area does this patent fall under?
Primary CPC classification C12P7/6463. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).